ACA
JNJ icon

Aptus Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Aptus Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.2M Sell
193,144
-6,081
-3% -$1.42M 0.37% 55
2025
Q4 		$41.2M Buy
199,225
+34,831
+21% +$6.89M 0.3% 66
2025
Q3 		$30.5M Buy
164,394
+1,910
+1% +$327K 0.22% 90
2025
Q2 		$24.8M Buy
162,484
+5,978
+4% +$919K 0.2% 103
2025
Q1 		$26M Sell
156,506
-12,753
-8% -$2M 0.27% 80
2024
Q4 		$24.5M Buy
169,259
+22,696
+15% +$3.52M 0.26% 87
2024
Q3 		$23.8M Buy
146,563
+42,059
+40% +$6.7M 0.35% 68
2024
Q2 		$15.3M Buy
104,504
+19,871
+23% +$2.96M 0.27% 83
2024
Q1 		$13.4M Buy
84,633
+10,399
+14% +$1.66M 0.25% 86
2023
Q4 		$11.6M Sell
74,234
-8,349
-10% -$1.28M 0.32% 76
2023
Q3 		$12.9M Buy
82,583
+3,345
+4% +$552K 0.35% 64
2023
Q2 		$13.1M Sell
79,238
-4,223
-5% -$682K 0.31% 71
2023
Q1 		$12.9M Sell
83,461
-5,257
-6% -$849K 0.35% 60
2022
Q4 		$15.7M Buy
88,718
+11,218
+14% +$1.94M 0.48% 44
2022
Q3 		$12.7M Buy
77,500
+5,177
+7% +$876K 0.3% 48
2022
Q2 		$12.8M Buy
72,323
+6,054
+9% +$1.08M 0.33% 41
2022
Q1 		$11.7M Buy
66,269
+10,440
+19% +$1.78M 0.29% 45
2021
Q4 		$9.55M Buy
55,829
+2,198
+4% +$360K 0.29% 54
2021
Q3 		$8.66M Buy
53,631
+7,048
+15% +$1.2M 0.22% 55
2021
Q2 		$7.67M Buy
46,583
+4,484
+11% +$742K 0.22% 55
2021
Q1 		$6.92M Sell
42,099
-5,061
-11% -$819K 0.25% 56
2020
Q4 		$7.42M Buy
47,160
+6,485
+16% +$957K 0.34% 55
2020
Q3 		$6.05M Buy
40,675
+2,689
+7% +$398K 0.32% 59
2020
Q2 		$5.34M Sell
37,986
-430
-1% -$62.7K 0.34% 54
2020
Q1 		$5.04M Sell
38,416
-5,069
-12% -$719K 0.44% 44
2019
Q4 		$6.34M Buy
43,485
+20,332
+88% +$2.76M 0.45% 42
2019
Q3 		$3M Buy
23,153
+16,819
+266% +$2.22M 0.17% 59
2019
Q2 		$882K Sell
6,334
-976
-13% -$135K 0.12% 132
2019
Q1 		$1.02M Buy
+7,310
New +$979K 0.17% 113

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aptus Capital Advisors's JNJ Position: Q1 2026 in Review

Aptus Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 3.1% in Q1 2026, selling an estimated $1.42M and leaving 193,144 shares worth $47.2M. The position accounts for 0.37% of the portfolio, ranked #55.

Aptus Capital Advisors first reported a position in JNJ in Q1 2019 and has held it in 29 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aptus Capital Advisors held 193,144 shares of Johnson & Johnson worth $47.2M as of Q1 2026.
  • Aptus Capital Advisors sold 6,081 Johnson & Johnson shares in Q1 2026, an estimated $1.42M.
  • Johnson & Johnson made up 0.37% of Aptus Capital Advisors's portfolio in Q1 2026, its #55 holding.
  • Aptus Capital Advisors first reported a position in Johnson & Johnson in Q1 2019 and has held it in 29 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.